<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ASTM</title>
    <link />
    <description>Headlines for AASTROM BIOSCIENCES, INC.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Aastrom Biosciences Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1417781-aastrom-biosciences-management-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 04:30:04 GMT</pubDate>
    </item>
    <item>
      <title>Stem Cells: Invest At Your Own Peril</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1388421-stem-cells-invest-at-your-own-peril.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 05:33:21 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Lows</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3538205/stocks-hitting-52-week-lows.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 29 Apr 2013 10:26:12 GMT</pubDate>
    </item>
    <item>
      <title>Investing In The Stem Cell Sector: An Overview</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1347281-investing-in-the-stem-cell-sector-an-overview.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 17 Apr 2013 08:36:00 GMT</pubDate>
    </item>
    <item>
      <title>Companies That Can Mend The Biotech Market: Stephen Brozak</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1338791-companies-that-can-mend-the-biotech-market-stephen-brozak.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 12 Apr 2013 17:40:32 GMT</pubDate>
    </item>
    <item>
      <title>Aastrom Biosciences Says First Patients Enrolled in ixCELL-DCM Phase 2b Clinical Trial of Ixmyelocel</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3471330/aastrom-biosciences-says-first-patients-enrolled-in-ixcell-dcm-phase-2b-clinical-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 04 Apr 2013 09:03:33 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Lows</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3454959/stocks-hitting-52-week-lows.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 28 Mar 2013 10:28:02 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Top Downgrades</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/downgrades/13/03/3454324/benzingas-top-downgrades.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 28 Mar 2013 08:33:34 GMT</pubDate>
    </item>
    <item>
      <title>Market Close: Big Winners &amp; Losers for March 27, 2013 (CHCI, RDHL, UEPS, RVLT, LIVE, ASTM, EVBS, ISN</title>
      <link>http://www.fool.com/news/xt/247wallst/247wallst.com/2013/03/27/market-close-big-winners-losers-for-march-27-2013-chci-rdhl-ueps-rvlt-live-astm-evbs-isns-atos-gv/.aspx?source=itxwebtxt0000015</link>
      <author>247wallst</author>
      <pubDate>Wed, 27 Mar 2013 16:26:09 GMT</pubDate>
    </item>
    <item>
      <title>Oppenheimer Reiterates Perform Rating on Aastrom Biosciences on Discontinuation of Phase III REVIVE</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3452053/oppenheimer-reiterates-perform-rating-on-aastrom-bioscie.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 27 Mar 2013 15:32:11 GMT</pubDate>
    </item>
    <item>
      <title>Aastrom's Shocking News And Future Potential</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1304181-aastrom-s-shocking-news-and-future-potential.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 27 Mar 2013 12:42:19 GMT</pubDate>
    </item>
    <item>
      <title>Morning Market Losers</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3451258/morning-market-losers.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 27 Mar 2013 10:40:46 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: MLV &amp; Co. Downgrades Aastrom Biosciences to Hold on Continued Disappointing Enrollment</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3432965/update-mlv-co-downgrades-aastrom-biosciences-to-hold-on-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 20 Mar 2013 12:14:33 GMT</pubDate>
    </item>
    <item>
      <title>What You Need To Know About Aastrom Bio</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1285141-what-you-need-to-know-about-aastrom-bio.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 20 Mar 2013 06:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Aastrom Biosciences Management Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1284571-aastrom-biosciences-management-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 18 Mar 2013 19:20:06 GMT</pubDate>
    </item>
    <item>
      <title>Aastrom Biosciences Finds a CEO</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/06/news-aastrom-biosciences-picks-a-ceo/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 06 Mar 2013 18:20:00 GMT</pubDate>
    </item>
    <item>
      <title>Is Takeda Interested In Aastrom Bio?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1228921-is-takeda-interested-in-aastrom-bio.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 27 Feb 2013 09:57:01 GMT</pubDate>
    </item>
    <item>
      <title>Stephen Brozak: Changing The Way Money Is Made And Diseases Are Cured</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1134421-stephen-brozak-changing-the-way-money-is-made-and-diseases-are-cured.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 25 Jan 2013 14:11:07 GMT</pubDate>
    </item>
    <item>
      <title>Stem Cell Stocks To Consider: Aastrom, Athersys, StemCells And Neuralstem</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1115611-stem-cell-stocks-to-consider-aastrom-athersys-stemcells-and-neuralstem.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 16 Jan 2013 14:35:39 GMT</pubDate>
    </item>
    <item>
      <title>Why Pluristem Therapeutics Is Poised to Plunge</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/16/why-pluristem-therapeutics-is-poised-to-plunge/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 16 Jan 2013 10:14:00 GMT</pubDate>
    </item>
  </channel>
</rss>
